The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

1,071

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2010

Study Completion Date

February 28, 2011

Conditions
Ischemic Stroke
Interventions
DRUG

Cerebrolysin

30 ml study drug will be given once daily by intravenous infusion for 10 consecutive days.

DRUG

0.9% Saline Solution

30 ml will be given once daily by intravenous infusion for 10 consecutive days.

Trial Locations (49)

Unknown

Mudanjiang 1st people Hospital, Mudanjiang

Mudanjiang 2nd people Hospital, Mudanjiang

Anhui Shengli Hospital, Anhui

Anshan hospital, Anshan

Baotou Center Hospital, Baotou

Third hospital, affiliated Neimenggu Medical University (Bao Gang hospital), Baotou

Beijing PLA General Hospital, Beijing

First hospital, affiliated Peking University, Beijing

Friendship Hospital, affiliated Capital Medical University, Beijing

Peking Anzhen Hospital, Beijing

Sino-Japanese Friendship Hospital, Beijing

First hospital, affiliated Bethune Medical University, Changchun

Second Hospital Affiliated Bethune Medical University, Changchun

Xiangya Hospital, affiliated Hunan Medical University, Changsha

Chengdu 2nd People's Hospital, Chengdu

First Hospital, affiliated Huaxi Medical University, Chengdu

Sichuan Province People's Hospital, Chengdu

Second Hospital, affiliated Chongqing Med. University, Chongqing

Dalian Center Hospital, Dalian

Dalian third people Hospital, Dalian

Second Hospital, affiliated Wenzhou Med. University, Dalian

First hospital, affiliated Fujian Medical University, Fuzhou

FuJian Shengli Hospital, Fuzhou

First Hospital, affiliated Shantou Medical University, Guandong

Guangzhou 2nd People's Hospital, Guangzhou

Guangzhou red cross hospital, Guangzhou

First Hospital, affiliated Medical college Zhejing University, Hangzhou

The 4st Hospital affiliated Harbin Medical University, Harbin

Second Hospital, affiliated Kunming Med. University, Kunming

Yinchuan People's Hospital, Mudanjiang

Nanjing PLA General Hospital, Nanjing

Zhongda Hospital, Nanjing

First Hospital, affiliated Qingdao Medical University, Qingdao

Huashan Hospital, affiliated Fudan University, Shanghai

Renji Hospital, affiliated Second Medical University, Shanghai

Ruijin Hospital, affiliated Jiaotong University, Shanghai

Shanghai 6th People's Hospital, Shanghai

Xinhua hospital of Shanghai Jiaotong University School of Medicine, Shanghai

Zhongshan Hospital, affiliated Fudan University, Shanghai

Hebei Province People's Hospital, Shijiazhuang

Tianjin First Medical Center, Tianjin

Tianjin Union Medicine Centre, Tianjin

Union Hospital, affiliated Huazhong science and technology University, Wuhan

First hospital, affiliated NingXia Mededical University, Yinchuan

First hospital, affiliated Henan Medical University, Zhengzhou

Chinese University of Hong Kong, Hong Kong

Asan medical center, Seoul

East-west neo medical center, Seoul

Kyung-hee University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Excel PharmaStudies, Inc.

INDUSTRY

collaborator

idv Datenanalyse und Versuchsplanung

UNKNOWN

lead

Ever Neuro Pharma GmbH

INDUSTRY

NCT00868283 - The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter